Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin
Clinical trial NCT00162812 · TERMINATED
Trial details
- NCT number
- NCT00162812
- Sponsor
- Jules Bordet Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Primary completion
- 2008-12-01
- Enrollment
- 338
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.